Drew Hannaman

2.4k total citations
55 papers, 1.6k citations indexed

About

Drew Hannaman is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Drew Hannaman has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 18 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Drew Hannaman's work include Immunotherapy and Immune Responses (19 papers), Viral gastroenteritis research and epidemiology (10 papers) and Transgenic Plants and Applications (10 papers). Drew Hannaman is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Viral gastroenteritis research and epidemiology (10 papers) and Transgenic Plants and Applications (10 papers). Drew Hannaman collaborates with scholars based in United States, Germany and United Kingdom. Drew Hannaman's co-authors include Alain Luxembourg, Barry Ellefsen, Claire F. Evans, Lesley C. Dupuy, Connie S. Schmaljohn, Klaus Überla, Brian Livingston, Shiwen Peng, T.‐C. Wu and Chien‐Fu Hung and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Drew Hannaman

55 papers receiving 1.6k citations

Peers

Drew Hannaman
Denise M. McKinney United States
Ludwig Deml Germany
Mark L. Bagarazzi United States
Gregory J. Tobin United States
Lynda Tussey United States
Minchao Chen United States
Kesen Dang United States
David C. Flyer United States
Denise M. McKinney United States
Drew Hannaman
Citations per year, relative to Drew Hannaman Drew Hannaman (= 1×) peers Denise M. McKinney

Countries citing papers authored by Drew Hannaman

Since Specialization
Citations

This map shows the geographic impact of Drew Hannaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Hannaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Hannaman more than expected).

Fields of papers citing papers by Drew Hannaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew Hannaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Hannaman. The network helps show where Drew Hannaman may publish in the future.

Co-authorship network of co-authors of Drew Hannaman

This figure shows the co-authorship network connecting the top 25 collaborators of Drew Hannaman. A scholar is included among the top collaborators of Drew Hannaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drew Hannaman. Drew Hannaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terry, Frances, Leonard Moise, Drew Hannaman, et al.. (2017). An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice. Human Vaccines & Immunotherapeutics. 13(12). 2824–2836. 24 indexed citations
2.
Garrison, Aura R., Charles J. Shoemaker, Joseph W. Golden, et al.. (2017). A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. PLoS neglected tropical diseases. 11(9). e0005908–e0005908. 80 indexed citations
3.
Datta, Dibyadyuti, Geetha P. Bansal, Dietlind L. Gerloff, et al.. (2016). Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation. Vaccine. 35(2). 264–272. 20 indexed citations
4.
Hannaman, Drew, Lesley C. Dupuy, Barry Ellefsen, & Connie S. Schmaljohn. (2016). A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. Vaccine. 34(31). 3607–3612. 45 indexed citations
6.
Temchura, Vladimir, Franco Pissani, Katrin Ehrhardt, et al.. (2015). Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells. The Journal of Immunology. 195(10). 4861–4872. 31 indexed citations
8.
Keane‐Myers, Andrea, et al.. (2014). DNA Electroporation of Multi-agent Vaccines Conferring Protection Against Select Agent Challenge: TriGrid Delivery System. Methods in molecular biology. 1121. 325–336. 5 indexed citations
9.
Yuan, Jianda, Geoffrey Y. Ku, Matthew Adamow, et al.. (2013). Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma. Journal for ImmunoTherapy of Cancer. 1(1). 20–20. 38 indexed citations
10.
Tippler, Bettina, Drew Hannaman, Christina Ehrhardt, et al.. (2013). Protective Efficacy and Immunogenicity of a Combinatory DNA Vaccine against Influenza A Virus and the Respiratory Syncytial Virus. PLoS ONE. 8(8). e72217–e72217. 21 indexed citations
11.
Kumar, Rajesh, Ruth Nyakundi, Thomas Kariuki, et al.. (2013). Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons. Vaccine. 31(31). 3140–3147. 27 indexed citations
12.
Buronfosse, Thierry, Catherine Jamard, Sylviane Guérret, et al.. (2012). Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation. Virology. 425(1). 61–69. 11 indexed citations
13.
Grant-Klein, Rebecca J., et al.. (2012). A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge. Human Vaccines & Immunotherapeutics. 8(11). 1703–1706. 36 indexed citations
14.
Albrecht, Mark T., et al.. (2012). Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague. Vaccine. 30(32). 4872–4883. 15 indexed citations
15.
Tenbusch, Matthias, Ralf Ignatius, Godwin Nchinda, et al.. (2012). Immunogenicity of DNA Vaccines Encoding Simian Immunodeficiency Virus Antigen Targeted to Dendritic Cells in Rhesus Macaques. PLoS ONE. 7(6). e39038–e39038. 28 indexed citations
17.
Livingston, Brian, Stephen F. Little, Alain Luxembourg, Barry Ellefsen, & Drew Hannaman. (2009). Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine. 28(4). 1056–1061. 45 indexed citations
18.
Luxembourg, Alain, Drew Hannaman, Ken N. Wills, et al.. (2008). Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens. Vaccine. 26(32). 4025–4033. 18 indexed citations
19.
Hannaman, Drew, et al.. (2007). Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation. Vaccine. 26(2). 185–192. 38 indexed citations
20.
Luxembourg, Alain, Claire F. Evans, & Drew Hannaman. (2007). Electroporation-based DNA immunisation: translation to the clinic. Expert Opinion on Biological Therapy. 7(11). 1647–1664. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026